Tech Company Financing Transactions
Crux Biomedical Funding Round
Crux Biomedical, operating out of Menlo Park, received $350 thousand in investment from Emergent Medical Partners.
Transaction Overview
Company Name
Announced On
12/31/2008
Transaction Type
Venture Equity
Amount
$350,000
Round
Undisclosed
Investors
Emergent Medical Partners (Christopher Schaffer)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1455 Adams Drive 1170
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The company is developing a retrievable Inferior Vena Cava (IVC) filter that promises to be a great improvement over existing modes of treatment. The device has been successfully tested in animal studies in2006 and was recently implanted in humans. Crux is currently working with the FDA to design and implement large-scale human clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mel Schatz
Chief Financial Officer
Chris Schaffer
VP - Operations
Murli Srinivasan
VP - R & D
Eric Johnson
VP - Regulatory Affairs
Elisa Hebb
Browse more venture capital transactions:
Prev: 12/31/2008: AlterPoint venture capital transaction
Next: 12/31/2008: Apieron venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs